Abstract
First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1002/14651858.cd010383.pub3
Publication Date: Mar 18, 2021 | |
Citations: 37 |
First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Join us for a 30 min session where you can share your feedback and ask us any queries you have